These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32849853)

  • 1. Identification of a Five-Gene Signature for Predicting Survival in Malignant Pleural Mesothelioma Patients.
    Bai Y; Wang X; Hou J; Geng L; Liang X; Ruan Z; Guo H; Nan K; Jiang L
    Front Genet; 2020; 11():899. PubMed ID: 32849853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of a Prognostic Signature for Malignant Pleural Mesothelioma.
    Zhou JG; Zhong H; Zhang J; Jin SH; Roudi R; Ma H
    Front Oncol; 2019; 9():78. PubMed ID: 30828567
    [No Abstract]   [Full Text] [Related]  

  • 3. Identification of glycolysis genes signature for predicting prognosis in malignant pleural mesothelioma by bioinformatics and machine learning.
    Xiao Y; Huang W; Zhang L; Wang H
    Front Endocrinol (Lausanne); 2022; 13():1056152. PubMed ID: 36523602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment and validation of a novel immune-related prognostic signature in malignant pleural mesothelioma.
    Zhang X; Huang X; Wang Z; Zhang K
    Ann Transl Med; 2022 Feb; 10(4):200. PubMed ID: 35280360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
    Wu M; Li X; Zhang T; Liu Z; Zhao Y
    Front Oncol; 2019; 9():996. PubMed ID: 31612115
    [No Abstract]   [Full Text] [Related]  

  • 6. KIAA0101 in Malignant Pleural Mesothelioma: A Potential Diagnostic and Prognostic Marker.
    Lin P; Zhao Y; Li X; Liang Z
    Comb Chem High Throughput Screen; 2022; 25(9):1498-1506. PubMed ID: 34238152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and clinical significance of SETD2 in maligant pleural mesothelioma].
    Yu M; Yu M; Zhu LJ; Yuan XY; Zhang X
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Feb; 39(2):91-98. PubMed ID: 33691361
    [No Abstract]   [Full Text] [Related]  

  • 8. Four Immune-Related Genes (FN1, UGCG, CHPF2 and THBS2) as Potential Diagnostic and Prognostic Biomarkers for Carbon Nanotube-Induced Mesothelioma.
    Xie D; Hu J; Wu T; Cao K; Luo X
    Int J Gen Med; 2021; 14():4987-5003. PubMed ID: 34511983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma.
    Wu M; Yuan H; Li X; Liao Q; Liu Z
    Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.
    Xia R; Tang H; Shen J; Xu S; Liang Y; Zhang Y; Gong X; Min Y; Zhang D; Tao C; Wang S; Zhang Y; Yang J; Wang C
    Cancer Cell Int; 2021 Mar; 21(1):154. PubMed ID: 33663535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma.
    Kim K; Ko Y; Oh H; Ha M; Kang J; Kwon EJ; Kang JW; Kim Y; Heo HJ; Kim G; Kim JW; Kim YH
    J Toxicol Environ Health A; 2020 Feb; 83(3):126-134. PubMed ID: 32114955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease.
    Cavalleri T; Angelici L; Favero C; Dioni L; Mensi C; Bareggi C; Palleschi A; Rimessi A; Consonni D; Bordini L; Todaro A; Bollati V; Pesatori AC
    PLoS One; 2017; 12(5):e0176680. PubMed ID: 28472171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Microenvironment-Associated Immune-Related Genes for the Prognosis of Malignant Pleural Mesothelioma.
    Xu X; Cheng L; Fan Y; Mao W
    Front Oncol; 2020; 10():544789. PubMed ID: 33042835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer.
    Chen Y; Xu R; Ruze R; Yang J; Wang H; Song J; You L; Wang C; Zhao Y
    Cancer Cell Int; 2021 Jun; 21(1):291. PubMed ID: 34090418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic risk assessment model for alternative splicing events and splicing factors in malignant pleural mesothelioma.
    Jiang Y; Zhang C; Chen Y; Zhao S; He Y; He J
    Cancer Med; 2023 Feb; 12(4):4895-4906. PubMed ID: 36031798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration.
    Shi J; Peng B; Zhou X; Wang C; Xu R; Lu T; Chang X; Shen Z; Wang K; Xu C; Zhang L
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12089-12102. PubMed ID: 37421452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma.
    Wang P; Wu M; Tu Z; Tao C; Hu Q; Li K; Zhu X; Huang K
    Front Oncol; 2020; 10():1119. PubMed ID: 32974125
    [No Abstract]   [Full Text] [Related]  

  • 18. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
    Yang H; Han M; Li H
    Front Oncol; 2020; 10():707. PubMed ID: 32432045
    [No Abstract]   [Full Text] [Related]  

  • 19. Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions.
    Pass HI; Wali A; Tang N; Ivanova A; Ivanov S; Harbut M; Carbone M; Allard J
    Ann Thorac Surg; 2008 Jan; 85(1):265-72; discussion 272. PubMed ID: 18154821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma.
    Yasumitsu A; Tabata C; Tabata R; Hirayama N; Murakami A; Yamada S; Terada T; Iida S; Tamura K; Fukuoka K; Kuribayashi K; Nakano T
    J Thorac Oncol; 2010 Apr; 5(4):479-83. PubMed ID: 20357617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.